Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Share-based Compensation (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Share-based Compensation for 5 consecutive years, with $555000.0 as the latest value for Q4 2020.

  • On a quarterly basis, Share-based Compensation rose 1690.32% to $555000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $956000.0, a 54.19% decrease, with the full-year FY2024 number at $3.1 million, down 5.76% from a year prior.
  • Share-based Compensation was $555000.0 for Q4 2020 at Forte Biosciences, up from $375000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $2.1 million in Q3 2019 to a low of -$2.0 million in Q2 2019.
  • A 5-year average of $784350.0 and a median of $542000.0 in 2017 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: tumbled 219.44% in 2019, then skyrocketed 1690.32% in 2020.
  • Forte Biosciences' Share-based Compensation stood at $403000.0 in 2016, then surged by 241.19% to $1.4 million in 2017, then rose by 27.27% to $1.8 million in 2018, then plummeted by 98.23% to $31000.0 in 2019, then surged by 1690.32% to $555000.0 in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Share-based Compensation are $555000.0 (Q4 2020), $375000.0 (Q3 2020), and $24000.0 (Q2 2020).